Nasdaq News
First Abu Dhabi Bank's profit hit by impairment charges
First Abu Dhabi Bank, the biggest lender in the United Arab Emirates (UAE), reported a 22% drop in quarterly profit on Monday, hit by interest rate cuts and impairment charges.
Regeneron, Sanofi Say Kevzara Will Now Only Be Tested in Sickest COVID-19 Patients
Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi (NASDAQ: SNY) announced on Monday that a late-stage study evaluating Kevzara as a treatment for COVID-19 will be changed to only enroll COVID-19 patients in critical condition and only use a higher dose of the drug. The study p
3 Stocks to Buy With Dividends Yielding More Than 5%
Stocks that pay out steady and increasing dividends are always appreciated by investors, but in times of market uncertainty and volatility, it is even more important. Not only does that regular cash payment provide income and offset potential losses, it also signals the stabilit
Wall Street gathers steam as U.S. states prepare to reopen
U.S. stock markets jumped more than 1% on Monday as more states prepared to ease stay-at-home orders and investors geared up for one of the busiest weeks of quarterly earnings reports, including from tech titans Apple and Microsoft.
RDFN Crosses Above Key Moving Average Level
In trading on Monday, shares of Redfin Corp (Symbol: RDFN) crossed above their 200 day moving average of $19.81, changing hands as high as $20.25 per share. Redfin Corp shares are currently trading up about 4.1% on the day. The chart below shows the one year performance of R
S&P 500 Analyst Moves: CERN
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Cerner is now the #52 analyst pick, moving up by 26 spots.
FB Crosses Above Key Moving Average Level
In trading on Monday, shares of Facebook Inc (Symbol: FB) crossed above their 200 day moving average of $191.34, changing hands as high as $193.75 per share. Facebook Inc shares are currently trading up about 1.4% on the day. The chart below shows the one year performance of
Stocks Jump Over 1% on Dow’s Third Day in the Green
A nice late-session advance helped the major indices end sharply higher on Friday, but it wasn’t enough to keep the market’s weekly winning streak alive. The big news this week was oil, as its May contract plunged into negative territory on Monday. As a result, stocks drop
Vossloh Q1 Preliminary EBIT Surges; Affirms FY20 Outlook - Quick Facts
(RTTNews) - German rail technology company Vossloh Group (VOSSF.PK) on Monday announced preliminary results for the first quarter of 2020.
Lockdown Easing + Monetary Easing = Rally in Risk
A strong risk-on rally in stocks and in both Asia and Europe started off the weak on a positive note and send the dollar lower as well on hopes that some of the more draconian lockdown measures in Western economies will be eased soon.
6 Ways to Make the Most of Your COVID-19 Stimulus Check
COVID-19 has been hurting the U.S. economy since cases started multiplying rapidly in March. Since then, millions of Americans have lost their jobs, while countless businesses have had to close their doors, perhaps for good.
Daily Markets: On Tap This Week -- Earnings Deluge, Central Banker Meetings, and Oil
This week will be a full plate for investors given the volume of quarterly earnings to be reported, several key central bank meetings, and the latest pandemic developments, including a growing number of plans being released to open economies in Europe and the US
This Generation Has Had the Biggest Credit Score Increase
Credit scores have been going up for most Americans, according to recent data from Experian. As more people monitor their credit, learn about the importance of their score, and come to understand the factors that could increase it or decrease it, it makes sense that the average
Neurocrine : FDA Approves Ongentys As Add-On Treatment For Parkinson's Disease
(RTTNews) - Neurocrine Biosciences Inc. (NBIX) said that the U.S. Food and Drug Administration has approved once-daily oral Ongentys or opicapone 25 mg and 50 mg capsules as an add-on treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing "off" episode
Regeneron, Sanofi To Amend Trial To Enroll Only Critical COVID-19 Patients
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi announced the preliminary results from the phase 2 portion of an ongoing phase 2/3 trial evaluating Kevzara (sarilumab), an interleukin-6 receptor antibody, in hospitalized patients with severe or critical respiratory
2 Top Biotech Stocks Under $10
Stocks priced below $10 a share can be a mixed bag. Low share prices are often indicative of companies with poor fundamentals, a weak near-term outlook, and a large number of outstanding shares. These types of equities, in turn, tend to be exceptionally risky and highly volatile
UK considers error range for GDP data due to COVID uncertainty
Economic output figures could soon come with error ranges around them, to better capture uncertainty around an historic slump that is expected to follow Britain's coronavirus shutdown, statisticians said on Monday.
Besides Remdesivir, These 2 COVID-19 Treatments Could Have Promise
In the mission to defeat COVID-19, scientists from all over the world are racing two develop two avenues of treatment: an effective therapy, and eventually a vaccine. This is so important to the investing world because we won't be able to go back to a 100% economy, with travel a
Mediaset executive wages cut in coronavirus emergency
Top managers at Mediaset have taken a pay cut, Italy's biggest commercial broadcaster said on Monday, as part of efforts to safeguard the group's finances during the coronavirus crisis.
Pagination
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed